Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galmed Pharmaceuticals Ltd
GLMDCurrent price
0.36 USD
-0.053 USD (-12.93%)
Last closed
0.4 USD
Company
www.galmedpharma.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 474 914 USD
Yield for 12 month
+23.10 %
Week
Month
Year
GLMD
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel. Address: 16 Tiomkin Street, Tel Aviv, Israel, 6578317
Analytics
WallStreet Target Price
1 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures GLMD
1 year
3 years
5 years
10 years
EBITDA
-7 756 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.29 %
PEG Ratio
–
Return On Equity TTM
-48.15 %
Wall Street Target Price
1 USD
Revenue TTM
–
Book Value
3.88 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings Share
-3.02 USD
Diluted Eps TTM
-3.02 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GLMD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GLMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
15.05.2023
Dividend Date
–
Stock Valuation GLMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
1.5272
Price Book MRQ
0.0944
Financials GLMD
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators GLMD
For 52 weeks
0.26 USD
14.18 USD
50 Day MA
0.42 USD
Shares Short Prior Month
10 970
200 Day MA
1.24 USD
Short Ratio
0.39
Shares Short
12 845
Short Percent
0.34 %
Google
Apple
Facebook